Updated review on novel therapies and ongoing clinical trials for high-risk non-muscle invasive bladder cancer

Updated review on novel therapies and ongoing clinical trials for high-risk non-muscle invasive bladder cancer

Purpose of reviewThe treatment options for high-risk non-muscle invasive bladder cancer (NMIBC), particularly in the setting of BCG-unresponsive disease, remain limited. We provide updates on recent, promising trials for high-risk NMIBC and newly FDA approved therapies.Recent findingsSeveral therapi...

Full description

Saved in:
Bibliographic Details
Main Authors: Brett Wiesen, Paige Hargis, Hunter Flores, Janet Kukreja
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Oncology
Subjects:
non muscle invasive bladder cancer
novel therapies
clinical trials
review
BCG (Bacille Calmette-Guérin)
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1519428/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items